Medifast
MED
129 hedge funds and large institutions have $157M invested in Medifast in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 30 closing their positions.
24% more call options, than puts
Call options by funds: $7.05M | Put options by funds: $5.68M
2.2% less ownership
Funds ownership: 83.76% → 81.56% (-2.2%)
8% less funds holding
Funds holding: 140 → 129 (-11)
10% less capital invested
Capital invested by funds: $175M → $157M (-$18.2M)
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
37% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$2.04M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.93M |
| 3 |
Two Sigma Advisers
New York
|
+$1.85M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.59M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.9M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.35M |
| 3 |
Renaissance Technologies
New York
|
-$1.9M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$960K |
MED Hedge Fund Activity: Q4 2024 in Review
129 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2024, worth a combined $157M — down 10% from $175M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of MED and 19 opened new positions — a net loss of 11 holders — while 46 trimmed existing stakes and 35 added.
The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $2.04M. The largest seller was AQR Capital Management, cutting an estimated $3.9M.
- 129 institutional investors held Medifast (MED) as of Q4 2024, down from 140 in Q3 2024.
- Funds reported $157M of Medifast stock for Q4 2024, down 10% quarter-over-quarter.
- 19 funds opened new Medifast positions in Q4 2024 and 30 closed out, a net change of -11 holders.
- The largest Medifast buyer in Q4 2024 was Prescott Group Capital Management, an estimated $2.04M added.
- The largest Medifast seller in Q4 2024 was AQR Capital Management, an estimated $3.9M sold.
Based on aggregated 13F filings for Q4 2024.